GenruiX Decides to Convene an Extraordinary General Meeting

Hello everyone! Today, we're bringing you news about GenruiX, a company specializing in cancer diagnostic technologies. GenruiX has recently decided to convene an extraordinary general meeting of shareholders with the agenda of appointing new directors. This announcement was made on July 28, 2026, and we encourage all shareholders to take note of this important information.

Extraordinary General Meeting Schedule and Agenda

GenruiX's extraordinary general meeting is scheduled to be held on September 9, 2026. The exact time and location will be announced at a later date, so please keep this in mind, shareholders. The record date for voting rights is August 12, 2026, and the board resolution date was confirmed as July 28, 2026.

The main agenda item for this extraordinary general meeting is the appointment of directors. However, the detailed agenda has not yet been finalized and is expected to be disclosed through a subsequent amendment notice, so it's worth keeping a close watch.

Board Meeting and Attendance Status

At the time of the board meeting, one outside director was absent, while the audit committee members were reported to be in attendance. This attendance record will help shareholders understand the proceedings of the board meeting.

GenruiX's Financial Status

You might also be curious about GenruiX's separate financial status as of the fiscal year-end December 2025. The following figures have been reported:

• Total Assets: 32.1 billion KRW
• Total Liabilities: 15.7 billion KRW
• Total Equity: 16.4 billion KRW
• Revenue: 7.5 billion KRW
• Operating Loss: 6.6 billion KRW
• Net Loss: 7.4 billion KRW

This financial information serves as crucial data for understanding GenruiX's management performance.

GenruiX's Stock Price Trend

Lastly, let's take a look at GenruiX's stock price trend. As of July 28, 2026, GenruiX's stock price was 1,479 KRW, marking a decrease of 93 KRW (-5.92%) compared to the previous day. Stock price fluctuations are closely related to a company's business performance, so shareholders should pay close attention to this as well.

GenruiX, listed on the KOSDAQ market on June 25, 2020, operates in the sector of manufacturing medical supplies and other pharmaceutical-related products. We hope you will continue to show great interest in GenruiX's future endeavors.